Candel Therapeutics (CADL) Change in Account Payables (2020 - 2025)
Candel Therapeutics (CADL) reported Change in Account Payables of $33000.0 for Q4 2025, up 158.93% on a YoY basis from $12744.8 in Q4 2024, and up 104.44% sequentially from -$744000.0 in Q3 2025.
Candel Therapeutics (CADL) Change in Account Payables (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of Change in Account Payables data on file, last reported at $33000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables rose 158.93% year-over-year to $33000.0; the trailing twelve-month figure through Dec 2025 stood at $802000.0 (up 533.51% YoY), and the FY2025 full-year result was $802000.0, up 533.51% from the prior year.
- Change in Account Payables rose to $33000.0 in Q4 2025, from -$744000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q2 2025 to a low of -$744000.0 in Q3 2025.
- A 5-year average of $5900.0 and a median of -$3000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 434.68% in 2022 and soared 2679.49% in 2025, its largest moves.
- Tracing CADL's Change in Account Payables over 5 years: stood at $665000.0 in 2021, then tumbled by 181.8% to -$544000.0 in 2022, then jumped by 131.62% to $172000.0 in 2023, then sank by 132.56% to -$56000.0 in 2024, then surged by 158.93% to $33000.0 in 2025.
- Business Quant data shows CADL's Change in Account Payables at $33000.0 in Q4 2025, -$744000.0 in Q3 2025, and $1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | 33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | -744,000.00 |
| Sep 30, 2025 | -744,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 507,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 172,000.00 |
| Dec 31, 2023 | 172,000.00 |
| Sep 30, 2023 | -214,000.00 |
| Sep 30, 2023 | -214,000.00 |